Two Sigma Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Two Sigma Securities’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-34,200	Closed	-$616K	–	3129
2024 Q3	$616K	Sell	34,200 -79,300	-70%	-$1.39M	0.01%	1165
2024 Q2	$1.84M	Sell	113,500 -112,500	-50%	-$1.73M	0.02%	751
2024 Q1	$3.19M	Buy	226,000 +204,900	+971%	+$2.58M	0.03%	553
2023 Q4	$220K	Buy	+21,100	New	+$197K	﹤0.01%	2299
2022 Q4	–	Sell	-40,600	Closed	-$328K	–	3249
2022 Q3	$328K	Buy	+40,600	New	+$359K	0.01%	1485
2021 Q3	–	Sell	-22,600	Closed	-$224K	–	1954
2021 Q2	$224K	Buy	+22,600	New	+$239K	0.01%	1210
2021 Q1	–	Sell	-67,300	Closed	-$649K	–	1702
2020 Q4	$649K	Buy	+67,300	New	+$645K	0.02%	574
2020 Q2	–	Sell	-63,300	Closed	-$568K	–	1731
2020 Q1	$568K	Buy	+63,300	New	+$649K	0.01%	573
2019 Q3	–	Sell	-52,300	Closed	-$483K	–	2450
2019 Q2	$483K	Sell	52,300 -144,300	-73%	-$1.74M	0.01%	1139
2019 Q1	$3.08M	Buy	196,600 +23,800	+14%	+$420K	0.03%	236
2018 Q4	$2.67M	Sell	172,800 -424,300	-71%	-$8.7M	0.03%	275
2018 Q3	$12.9M	Buy	597,100 +56,500	+10%	+$1.31M	0.08%	161
2018 Q2	$13.1M	Sell	540,600 -205,900	-28%	-$4.2M	0.07%	222
2018 Q1	$12.8M	Buy	746,500 +700,600	+1,526%	+$13.7M	0.07%	229
2017 Q4	$870K	Buy	+45,900	New	+$690K	0.02%	467

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Two Sigma Securities's TEVA Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 6,797 shares worth $230K. The stake represents 0.02% of the portfolio and ranks #1073 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in TEVA as recently as Q2 2024.

Two Sigma Securities first reported a position in TEVA in Q1 2016 and has held it in 26 quarters since. The position peaked at $2.54M in Q3 2016. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Two Sigma Securities held 6,797 shares of Teva Pharmaceuticals worth $230K as of Q2 2026.
Teva Pharmaceuticals was a new Two Sigma Securities position in Q2 2026.
Teva Pharmaceuticals made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #1073 holding.
Two Sigma Securities first reported a position in Teva Pharmaceuticals in Q1 2016 and has held it in 26 quarters since.
Two Sigma Securities's Teva Pharmaceuticals position peaked at $2.54M in Q3 2016.
675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.